U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H42NO6.Na
Molecular Weight 487.6045
Optical Activity UNSPECIFIED
Defined Stereocenters 11 / 11
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM GLYCOCHOLATE

SMILES

[Na+].[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCC([O-])=O

InChI

InChIKey=OABYVIYXWMZFFJ-ZUHYDKSRSA-M
InChI=1S/C26H43NO6.Na/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29;/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33);/q;+1/p-1/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C26H42NO6
Molecular Weight 464.6148
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 11
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Glycocholic acid (GCA) is an important metabolite of bile acids, a conjugate of cholic acid with glycine. GCA urine levels are expected to be a specific diagnostic biomarker for hepatocellular carcinoma (HCC). The average GCA concentrations of HCC patients in plasma and urine were about 25 and 2.8 times than that of healthy volunteers.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Ocular tolerance of absorption enhancers in ophthalmic preparations.
2002
Bile salt aggregates in the gas phase: an electrospray ionization mass spectrometric study.
2002 Apr 15
Solubilization of drugs by physiological mixtures of bile salts.
2002 Aug
Examination of the solubilization of drugs by bile salt micelles.
2002 Aug
Maldigestion and malabsorption of dietary lipid during severe childhood malnutrition.
2002 Dec
Colesevelam hydrochloride.
2002 May 15
Functional expression of the canalicular bile salt export pump of human liver.
2002 Nov
The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.
2002 Nov
A monoclonal antibody-based enzyme-linked immunosorbent assay of glycolithocholic acid sulfate in human urine for liver function test.
2002 Sep
[Comparative characteristics of lipid components of gallbladder and liver bile fractions in children with chronic cholecystitis].
2003
Effect of sodium glycocholate on development of tolerance to Parthenium hysterophorus extracts.
2003 Apr
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane.
2003 Aug
Determination of ursodeoxycholic acid in pharmaceutical preparations by capillary electrophoresis with indirect UV detection.
2003 Aug 8
Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3.
2003 Feb
Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance.
2003 Feb 4
Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.
2003 Jan 1
Variation in plasma amino acid concentrations during a cycling competition.
2003 Jun
Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
2003 Mar
Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating arylsulfonylureido and 5-dibenzo-suberenyl/suberyl moieties.
2003 May 15
Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats.
2003 Nov
Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake.
2003 Nov
Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor.
2003 Oct
Steroid ring hydroxylation patterns govern cooperativity in human bile acid binding protein.
2003 Oct 14
Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium.
2004 Apr
Cytotoxicity evaluation of enzyme inhibitors and absorption enhancers in Caco-2 cells for oral delivery of salmon calcitonin.
2004 Apr
Functional assessment of bacterial colonization in patients with ileal pouch-anal anastomosis and Brooke ileostomy.
2004 Aug
Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway.
2004 Feb 1
Poly(N,N,N-trimethylammoniumalkyl acrylamide chloride) based hydrogels for serum cholesterol reduction.
2004 Jan-Feb
Acid and bile salts induce DNA damage in human oesophageal cell lines.
2004 Jul
Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging.
2004 Jul 1
Quantification of bile acids directly from plasma by MALDI-TOF-MS.
2004 Mar
Noninvasive methods to determine the critical micelle concentration of some bile acid salts.
2004 Nov 1
Adsorption of bile acid by chitosan-orotic acid salt and its application as an oral preparation.
2004 Oct
Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11.
2005 Apr
Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
2005 Apr 11
[Cholyl glycine (CG)].
2005 Aug
Ileal bile acid-binding protein, functionally associated with the farnesoid X receptor or the ileal bile acid transporter, regulates bile acid activity in the small intestine.
2005 Dec 23
Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
2005 Feb
Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11).
2005 Feb
Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.
2005 Jan
The influence of the ionic medium on the behaviour of sodium glycocholate and cholate aqueous solutions.
2005 Jan-Feb
Stable ciliary activity in human nasal epithelial cells grown in a perfusion system.
2005 Mar 23
Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly.
2005 May
mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
2005 Oct
Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism.
2005 Oct
Diastereomeric molecular recognition and binding behavior of bile acids by L/D-tryptophan-modified beta-cyclodextrins.
2005 Oct 28
Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles.
2005 Oct 3
Bile salts inhibit growth and induce apoptosis of human esophageal cancer cell line.
2005 Sep 7
Effect of tibolone on turnover of cholesterol to bile acids in ovariectomized rats.
2005 Sep-Oct
Inhibition of MRP1-mediated efflux in human erythrocytes by mono-anionic bile salts.
2005 Sep-Oct
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 16 16:23:28 UTC 2022
Edited
by admin
on Fri Dec 16 16:23:28 UTC 2022
Record UNII
V06CXA1W3K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM GLYCOCHOLATE
Common Name English
SODIUM CHOLYLGLYCINATE
Common Name English
SODIUM GLYCYLCHOLATE
Common Name English
MONOSODIUM GLYCOCHOLATE
Common Name English
N-CHOLYLGLYCINE SODIUM SALT
Common Name English
NSC-35609
Code English
GLYCOCHOLIC ACID, SODIUM SALT
Common Name English
GLYCINE, N-((3.ALPHA.,5.BETA.,7.ALPHA.,12.ALPHA.)-3,7,12-TRIHYDROXY-24-OXOCHOLAN-24-YL)-, SODIUM SALT (1:1)
Systematic Name English
Code System Code Type Description
CHEBI
36273
Created by admin on Fri Dec 16 16:23:28 UTC 2022 , Edited by admin on Fri Dec 16 16:23:28 UTC 2022
PRIMARY
CAS
863-57-0
Created by admin on Fri Dec 16 16:23:28 UTC 2022 , Edited by admin on Fri Dec 16 16:23:28 UTC 2022
PRIMARY
NSC
35609
Created by admin on Fri Dec 16 16:23:28 UTC 2022 , Edited by admin on Fri Dec 16 16:23:28 UTC 2022
PRIMARY
PUBCHEM
23670522
Created by admin on Fri Dec 16 16:23:28 UTC 2022 , Edited by admin on Fri Dec 16 16:23:28 UTC 2022
PRIMARY
ECHA (EC/EINECS)
212-730-9
Created by admin on Fri Dec 16 16:23:28 UTC 2022 , Edited by admin on Fri Dec 16 16:23:28 UTC 2022
PRIMARY
FDA UNII
V06CXA1W3K
Created by admin on Fri Dec 16 16:23:28 UTC 2022 , Edited by admin on Fri Dec 16 16:23:28 UTC 2022
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE